Sirona Biochem Corp.
SRBCF · OTC
7/31/2024 | 4/30/2024 | 1/31/2024 | 10/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | -$0 |
| % Growth | -77% | 604.8% | 105% | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | 100% | 77.8% | -52.8% | 108.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -26,035.5% | -3,784.3% | -41,693% | 1,791.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -34,808.5% | -3,774.6% | -46,588.9% | 2,000.9% |
| EPS Diluted | -0.003 | -0.002 | -0.003 | -0.003 |
| % Growth | -112.5% | 44.8% | -16% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |